Compare RNXT & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RNXT | CMBM |
|---|---|---|
| Founded | 2012 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.4M | 65.5M |
| IPO Year | 2021 | 2019 |
| Metric | RNXT | CMBM |
|---|---|---|
| Price | $0.97 | $1.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.75 | N/A |
| AVG Volume (30 Days) | 203.0K | ★ 1.5M |
| Earning Date | 11-13-2025 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $928,000.00 | ★ $172,215,000.00 |
| Revenue This Year | $2,795.35 | N/A |
| Revenue Next Year | $272.69 | $18.01 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.70 | $0.23 |
| 52 Week High | $1.69 | $6.80 |
| Indicator | RNXT | CMBM |
|---|---|---|
| Relative Strength Index (RSI) | 51.67 | 44.11 |
| Support Level | $0.83 | $1.41 |
| Resistance Level | $1.00 | $1.69 |
| Average True Range (ATR) | 0.06 | 0.21 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 71.95 | 27.45 |
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.